Clinical Trial Update: Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating a typhoid vaccine to test immune stress responses in patients with stage I-IIIA breast cancer. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Typhoid vaccine (Salmonella Typhi vaccine)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Cognitive Side Effects of Cancer Therapy, Depression | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-07-24